Skip to main content
. 2022 Jul 12;17:1081–1090. doi: 10.2147/CIA.S370970

Table 3.

Comparison of Outcomes of All Patients in Our Study

Outcomes Total (N=458) SOD GR
SOD ≤ 112.5 U/mL SOD > 112.5 U/mL P-value GR ≤ 52.5 U/L GR > 52.5 U/L P-value
3-month mortality 9 (3.0%) 5 (8.6%) 4 (1.6%) 0.018 7 (7.3%) 2 (1.0%) 0.008
6-month mortality 16 (5.3%) 9 (15.5%) 7 (2.9%) <0.001 12 (12.5%) 4 (2.0%) <0.001
1-year mortality 50 (16.6%) 23 (39.7%) 27 (11.1%) <0.001 28 (29.2%) 22 (10.7%) <0.001
3-month independent walking rate 58 (19.3%) 6 (10.3%) 52 (21.4%) 0.055 10 (10.4%) 48 (23.4%) 0.008
6-month independent walking rate 164 (54.5%) 17 (29.3%) 147 (60.5%) <0.001 36 (37.5%) 128 (62.4%) <0.001
1-year independent walking rate 202 (67.1%) 22 (37.9%) 243 (74.1%) <0.001 49 (51.0%) 153 (74.6%) <0.001